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Abstract
Background: Research evidence underpins best practice, but is not always used in healthcare. The Promoting
Action on Research Implementation in Health Services (PARIHS) framework suggests that the nature of evidence,
the context in which it is used, and whether those trying to use evidence are helped (or facilitated) affect the use
of evidence. Urinary incontinence has a major effect on quality of life of older people, has a high prevalence, and
is a key priority within European health and social care policy. Improving continence care has the potential to
improve the quality of life for older people and reduce the costs associated with providing incontinence aids.
Objectives: This study aims to advance understanding about the contribution facilitation can make to
implementing research findings into practice via: extending current knowledge of facilitation as a process for
translating research evidence into practice; evaluating the feasibility, effectiveness, and cost-effectiveness of two
different models of facilitation in promoting the uptake of research evidence on continence management;
assessing the impact of contextual factors on the processes and outcomes of implementation; and implementing a
pro-active knowledge transfer and dissemination strategy to diffuse study findings to a wide policy and practice
community.
Setting and sample: Four European countries, each with six long-term nursing care sites (total 24 sites) for people
aged 60 years and over with documented urinary incontinence
Methods and design: Pragmatic randomised controlled trial with three arms (standard dissemination and two
different programmes of facilitation), with embedded process and economic evaluation. The primary outcome is
compliance with the continence recommendations. Secondary outcomes include proportion of residents with
incontinence, incidence of incontinence-related dermatitis, urinary tract infections, and quality of life. Outcomes are
assessed at baseline, then at 6, 12, 18, and 24 months after the start of the facilitation interventions. Detailed
contextual and process data are collected throughout, using interviews with staff, residents and next of kin,
observations, assessment of context using the Alberta Context Tool, and documentary evidence. A realistic
evaluation framework is used to develop explanatory theory about what works for whom in what circumstances.
Trial registration: Current Controlled Trials ISRCTN11598502.
Background
Evidence-based healthcare has featured as a policy con-
cern in many healthcare systems for over a decade dri-
ven by a growing recognition and concern that
healthcare practice does not always reflect what is
known to be best practice. Some studies [1,2] suggest
that twenty to forty per cent of patients receive harmful
care or care that is inconsistent with scientific evidence.
Responding to these concerns, policy makers have
increasingly sought ways to narrow the research-practice
gap and ensure that research is translated into clinical
practice as effectively and efficiently as possible. Initia-
tives have included the establishment of national guide-
line development and technology assessment bodies
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[3,4] knowledge and skills development of healthcare
staff [5,6], and research programmes to investigate effec-
tive implementation methods and processes [7,8].
Despite significant investment, translating research in
to healthcare decision making and practice remains a
considerable challenge. In the United Kingdom (UK), a
national evaluation of the extent and pattern of imple-
mentation of guidance issued by the National Institute
for Health and Clinical Excellence (NICE) demonstrated
a highly variable level of uptake, ranging from no
change to significant changes in practice in line with the
guidance [9]. Additionally the literature contains numer-
ous examples of attempts to implement evidence into
practice; with mixed success [10-14]
Translating and using research in practice is complex,
involving significant and planned individual, team, and
organisational change. A case study meta analysis of evi-
dence into practice projects highlights the social, organi-
sational, and professional factors that mediate evidence
use [15] and are consistent with a review of the diffu-
sion of innovations literature, which emphasised the
complex interactions between clinicians and their prac-
tice settings [16], illustrating that there are no simple
solutions to complex healthcare problems.
The complexities inherent in the implementation of
evidence into practice are represented in the Promoting
Action on Research Implementation in Health Services
(PARIHS) framework [17-21]. In contrast to previous
frameworks that had represented implementation as a
linear and rationale process, PARIHS was developed to
demonstrate the complex interplay of a number of fac-
tors that influence the successful implementation of evi-
dence in practice [17]. Successful implementation is
represented as a function of the nature of evidence
being implemented, the context in which implementa-
tion takes place, and the way in which that process is
facilitated: SI = f(e, c, f).
The subsequent development and refinement of the
framework has been comprehensively described in
recent publications [19,20]. This development has
included concept analyses of the core concepts within
the framework: evidence [22], context [23], and facilita-
tion [24]. As a result, the framework has evolved to pro-
vide a map to enable others to make sense of the
complexities of implementation and the elements that
require attention if implementation is more likely to be
successful [21].
The PARIHS framework has been well received by
those working in the field of evidence-based healthcare,
and has been used by others as a heuristic to guide
implementation efforts at the point of care delivery
[25-27] and as the conceptual underpinning of a variety
of tools and measures [28,29]. A critical synthesis of
empirical studies in which the PARIHS framework was
used highlighted its strengths and issues. Their conclu-
sions included the need for further delineation of the
elements within the framework, and a call for the frame-
work to be used prospectively in implementation studies
[30]. The FIRE study is one attempt to do this, with a
particular focus on the facilitation dimension of the
PARIHS framework.
A key element of the PARIHS framework is facilita-
tion, which could be described as a mechanism or inter-
vention for the implementation of evidence into
practice. A facilitator is an individual who is skilled in
working with the concepts of change management and
individual and organisational development. Facilitation
involves the facilitator working with individuals, teams,
and organisations to prepare, guide, and support them
through the implementation process. This involves
attentiveness to both the context (including barriers and
enablers of change) and to the evidence to be imple-
mented and how it fits with local circumstances. Two
important features were identified in a concept analysis
of facilitation [24]. Firstly, not all efforts to get research
evidence into practice explicitly engage processes to
support implementation. In such cases, implementation
involved discrete interventions, such as the distribution
of printed materials or the provision of targeted educa-
tional meetings, the assumption being that on learning
about the new evidence, practitioners would change
their practice accordingly. Secondly, in cases where
interventions to promote implementation did involve an
individual taking on a facilitator role (for example, a
dedicated project lead, educational outreach worker, or
practice development facilitator), two models of facilita-
tion were apparent. These different models were repre-
sented along a continuum, ranging from a largely task-
focused, project manager role, to a more holistic,
enabling approach to facilitation where the facilitator
worked at the level of individuals, teams, and organisa-
tions to create and sustain a supportive context for evi-
dence based care [31,32].
The findings from the concept analysis of facilitation
suggest that the key to successful implementation is
matching the purpose, role, and skills of the facilitator
to the specific needs of the situation, i.e., appropriate
facilitation [24]. A systematic review of 26 studies con-
cluded that whilst tailored interventions can change
practice, there is a lack of evidence about how interven-
tions should be selected to address barriers, and no evi-
dence on cost effectiveness [33]. Given the increasingly
recognised complex nature of implementing research
evidence into practice and the need to address the inter-
play between individuals and the organisation [15,34], it
is reasonable to suggest that skilled facilitators need to
be able to move across different points of the facilitation
continuum to meet the different requirements of
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individuals, teams, and organisations at different points
in time. However, this requires facilitators to possess a
sophisticated range of knowledge and skills, including,
for example, diagnostic skills (to assess the organisa-
tional context and the needs of individuals and teams
within that context), project management skills, and a
range of skills to support individual, team, and organisa-
tional development and learning. In turn, this requires
significant investment of resources and time, both in
preparing and supporting individuals to take on the
facilitator role and in creating time for individuals and
teams to work with the facilitator to implement research
evidence into practice. Other issues to consider include
the need to distinguish between the facilitator role and
the methods that the facilitator uses, the complexity of
the role and how much facilitation is needed in a given
situation, and the need to better understand the rela-
tionship between facilitation, context, and evidence.
Despite the increasing use of facilitation type models
and techniques within implementation projects, to date,
facilitation has received little attention in the formal
classification of methods and interventions to change
professional and organisational behaviour (for example,
by the Cochrane review group on Effective Practice and
Organisation of Care). Systematic reviews of various
implementation interventions across a variety of settings
show mixed effects [35-37]. There is some evidence to
support the use of discrete interventions such as the dis-
tribution of printed materials, the use of reminders,
audit and feedback, participative education programmes,
and social marketing techniques. However, further
research is needed into the effectiveness of such imple-
mentation interventions, and more specifically there has
been a call for more theory informed interventions, and
robust and methodologically sound research [36,38,39].
This protocol describes a theory driven study to evalu-
ate the effectiveness of facilitation as an intervention to
implement evidence into practice. Drawing on the core
elements of evidence, context, and facilitation, we will
test a number of theoretical propositions about facilita-
tion and the implementation of continence promotion
evidence within nursing home settings across four Eur-
opean countries. The research will start to uncover the
relationship between particular facilitation methods and
the impact of the use of these methods on evidence use,
contextual change, team effectiveness, and the creation
of organisational infrastructures that support and enable
knowledge utilisation.
Methods
Aims
1. Extend current knowledge of facilitation as a process
for translating research evidence into practice. Based on
the PARIHS framework, two different models of
facilitation will be developed (described as technical
[Type A] and enabling [Type B] facilitation), requiring
different levels of facilitator skills and knowledge and
the application of different methods of implementation,
with corresponding different levels of resource require-
ments in terms of preparation and support of facilitators
and the ways in which they work with individuals and
teams who are attempting to implement research into
practice.
2. Evaluate the feasibility, effectiveness, and cost-effec-
tiveness of two different models of facilitation in pro-
moting the uptake of research evidence on continence
management. An intervention study in four countries
(England, Sweden, Republic of Ireland, Netherlands) will
be set up to test the two different models of facilitation
against a standard method of disseminating evidence of
best practice on continence promotion. Six units per
country will participate in the study (two units for each
of the three study arms). The research evidence to be
implemented will draw on existing evidence in the form
of systematic reviews and guidance on continence
management.
3. Assess the impact of contextual factors on the pro-
cesses and outcomes of implementation. The research
will be underpinned by a theory-driven methodology,
with a particular focus on explaining what works, for
whom, how and in what circumstances. A detailed set
of contextual, process, and outcome data will be col-
lected in all the study sites to track the processes of
implementation, to account for and explain contextual
differences between and within countries, to monitor
changes over time, and any diffusion beyond each study
setting.
4. Implementing a pro-active knowledge transfer and
dissemination strategy to diffusion of the study findings
to a wide policy and practice community. Dissemination
will be planned in parallel to the design and implemen-
tation of the study, reflecting the theory-driven nature
of the research and the importance of stakeholder invol-
vement at all stages of the research process. Stake-
holders will include the commissioners of the research,
key interest groups at a European level, and policy-
makers, managers, and practitioners in EU countries not
actively participating in the research. Stakeholder invol-
vement will inform the development and refinement of
theoretical propositions as the study progresses and
findings begin to emerge. A range of networking and
dissemination methods will be used to promote the
input and involvement of countries from throughout
Europe and beyond.
Overall design
The design of this study is a pragmatic randomised con-
trolled trial (RCT) with integral qualitative, quantitative
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and health economic evaluative components. The RCT
has three arms: standard dissemination of recommenda-
tions; standard dissemination plus Type A (technical)
facilitation; and standard dissemination plus Type B
(enabling) facilitation.
We will assess the impact of the different facilitation
programmes on processes and outcomes when imple-
menting continence recommendations in long-term nur-
sing care settings for older people. A dissemination or
knowledge transfer strategy runs concurrently with the
rest of the study.
Whilst researchers investigating knowledge translation
routinely collect summative data in RCTs of interven-
tions, they rarely collect process data (Grimshaw et al.
2004). Critical questions about the context of implemen-
tation, the feasibility of interventions, participant
response, and resource implications need to be
addressed in order to appraise why interventions worked
(or not), in what situations, and with which stake-
holders. This study has been designed to ensure that the
experimental design is combined with exploratory and
explanatory research in order to develop a richer and
more detailed picture of the process and impact of
implementation. As such, the findings of the study will
have the potential to significantly build on and contri-
bute to the international evidence base about research
implementation. This study enables us to explore the
factors that affect implementation over time within sites.
The process evaluation has been designed as a realistic
evaluation, and is embedded into the trial design. Realis-
tic evaluation [40] is particularly relevant for this work
because it aims to develop explanatory theory about
why interventions and strategies work, for whom, how,
and in what circumstances. This will allow a detailed
understanding of how the processes of facilitation relate
to outcomes. This multi-level evaluation will be theory-
driven and informed by key concepts within the pro-
gramme’s theoretical framework, and by knowledge
translation theory more broadly. The economic evalua-
tion is fully integrated into the evaluation and will con-
sider both the costs and consequences of the two
facilitation models compared to standard dissemination
of the continence recommendations.
Inclusion Criteria
Setting
Long-term nursing care settings with publically funded
places, at least 60 residents, are interested in taking part,
have residents who are aged 60 years or older, with
documented urinary incontinence. Settings will be
excluded if they have previously taken part in other
externally led improvement projects and/or where staff
have already had facilitation development.
Participants
Staff Staff who have consented to be involved as: inter-
nal facilitators engaged in intervention delivery; staff at
all levels working in sites delivering care; and key stake-
holders related to sites (e.g., community based nurse).
Residents All residents meeting the following criteria
are eligible for the study: aged 60 or over with no or
mild dementia who consent to access to their conti-
nence related notes and/or being observed and/or com-
pleting quality of life questionnaires and/or taking part
in interviews. Next of kin or consultee will be asked
about looking at continence-related notes of residents
with moderate to severe dementia. (A consultee is a per-
son who, as a result of an existing relationship with the
person who lacks capacity, can advise the researcher
about that person’s participation in the project).
Informal carers Informal carers such as next of kin of
residents who consent to be interviewed are eligible.
Exclusion criteria Residents with moderate to severe
dementia will not be interviewed or asked to complete
quality of life scales. However, advice from next of kin
or consultee will be sought about looking at their nur-
sing home notes about continence care. In addition,
next of kin or consultee of residents with moderate to
severe dementia will be asked to completed a proxy
quality of life scale (EQ-5D).
Facilitation intervention The participants on the facili-
tation development programmes, known as internal
facilitators, will be members of staff in the organisations
in which the long-term care settings are located. They
will be staff who are usually asked by their managers to
lead and/or facilitate projects, change, or innovate in
that organisation. Payment at a specified level will be
made by the study to meet the costs of covering shifts
while the internal facilitators take part in the study. The
facilitation programmes will be led by expert external
facilitators from the study team, working with the inter-
nal facilitators. To manage the risk associated with an
internal facilitator leaving during the study, a co-facilita-
tion model will be used, where a second person works
with the internal facilitator, using this as a development
opportunity, including taking the lead if the initial facili-
tator is unable to continue. This has been used success-
fully in other settings by the external facilitators [41].
Two facilitation programmes were developed (type A
and type B described below) to help participants imple-
ment recommendations for continence care in long-term
nursing care settings for older people. These two types of
facilitation intervention were informed by relevant theo-
retical and empirical knowledge, and facilitated by inter-
national experts in the area (the external facilitators).
Arm One – Control Group The control group will
receive standard dissemination that involves distributing
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the recommendations for continence care to the head of
the long-term care setting, with a PowerPoint presenta-
tion about implementation. This is seen as standard
practice (RCN 2007).
Arm Two – Type A facilitation plus standard disse-
mination This technical facilitation focuses particularly
on addressing issues of implementation at the level of
clinical teams, in terms of enabling them to design sys-
tems and processes of care that will enhance the transfer
of evidence into their day-to-day practice. Type A facili-
tation draws on an eclectic range of theories, derived
from management science, organisational learning, qual-
ity improvement, and humanistic psychology. It adopts a
pragmatic approach to implementation, whilst recognis-
ing the need to pay attention to task, group, and indivi-
dual needs. Individuals are prepared to take on the role
of facilitator and are provided with a ‘toolkit’ of methods
and techniques that they can use with health care teams
to facilitate both the task and the process of implement-
ing evidence [41]. This is a 12-month development pro-
gramme. Internal facilitators will have 19 days of
protected time over the year (this will consist of 10 days
to work on the implementation and evaluation of the
clinical guidelines; three days residential training; 12 half
days for monthly telecommunications support by exter-
nal facilitators and self-directed study). External facilita-
tors will require 16 days each over the 12 months to
fulfil their facilitation role. The external facilitators for
Type A facilitation are members of the study team (GH
and AK).
Arm Three – Type B facilitation plus standard disse-
mination This enabling facilitation uses critical social
science concepts (e.g., consciousness-raising, problemati-
sation, self-reflection, and critique) on the basis that the
emphasis on inquiry and the development of individual
practitioners, cultures, and contexts within which they
work, will result in overcoming difficulties, through
emancipatory action, and thus bring about sustainable
change. Such action is collaborative, inclusive, and parti-
cipative. Theoretical underpinnings also draw on critical
creativity and its focus on creating conditions for per-
son-centredness and human flourishing and engaging in
praxis (mindful, practical action) through professional
artistry. Enabling facilitation is concerned with change
and innovation, individual and team effectiveness, lea-
dership and evidence use and development. Recent evi-
dence suggests that practice development achieved
through enabling facilitation methods requires a mini-
mum of two years of sustained enabling facilitation [42].
Arm three, therefore, is a two-year, two-staged
intervention.
In stage one, the aim is to provide an opportunity for
internal facilitators to develop, use, and refine a practi-
tioner inquiry approach to enabling stakeholders in their
organisations to improve continence care of residents by
getting research into practice. This comprises the deliv-
ery of an 18-month enabling facilitation development
programme, including planning, implementation, and
evaluation of the continence recommendations. Stage
two is a six-month diffusion study with the aim of
enabling internal facilitators to develop further person-
centred, evidence-informed practice in their workplaces/
organisations. Internal facilitators will have 43 protected
days over the two years (20 days to work on the imple-
mentation, evaluation and diffusion of clinical guide-
lines, five days residential learning, 24 half day learning
groups supported via telecommunications by the exter-
nal facilitators), and 12 half days for self-directed study
and research, culminating in the production of a portfo-
lio of evidence. External facilitators will require 31 days
each over two years. The external facilitators for Type B
facilitation are BMcC and AT.
Criteria for selecting internal facilitators (for both
Type A and Type B facilitation) The following charac-
teristics are discussed with the manager of the setting to
select an appropriate internal facilitator:
1. Has some knowledge of good practice in continence
care and has an interest in the topic
2. Knows co-workers
3. Knows the environment
4. Knows the organisation
5. Occupies a clinical leadership position
6. Possesses effective communication skills
7. Is self-aware and resilient
8. Is reliable and dependable
Recommendations (the evidence) being implemented
A review of research evidence was conducted as part of
the fourth International Consultation on Incontinence
(ICI) [43]. They based their recommendations on grad-
ings derived from the Oxford Centre for Evidence Based
Medicine ‘Levels of Evidence’ [44]. Grading for thera-
peutic interventions included Grade A: consistent evi-
dence from meta-analysis of trials or good quality RCTs;
Grade B: consistent evidence from lower quality RCTs,
meta-analysis with homogeneity, good quality prospec-
tive cohort studies, good quality retrospective case con-
trols studies, good quality case series; Grade C: expert
opinion based on first principles or majority evidence
from study types listed in Grade B, or Delphi processed
expert opinion. Grade D: no recommendation is possible
as evidence is conflicting or expert opinion has not been
through a formal analytical process. They note that a
Grade A recommendation often means the recommen-
dation is effectively mandatory and placed within a clini-
cal care pathway.
The recommendations to be implemented in this
study were thus taken from the algorithm developed by
Committee 11 who examined the research relevant to
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Incontinence in the Frail Elderly [43]. The drafted
recommendations were then circulated to continence
experts in each country and the continence experts on
the study’s Advisory Committee. No country-specific
issues that may make their implementation problematic
were identified by the continence experts. The recom-
mendations [43] to be implemented in the FIRE study
are listed below, with their associated level of evidence.
Recommendations to be implemented in FIRE study
1. The patient/resident should be actively screened
for urinary incontinence.(Grade A)
2. A detailed assessment should be carried out
including:
• Relevant co-morbid conditions should be
assessed:
- rectal examination; constipation (Grade C)
- functional assessment (mobility, transfer,
dexterity, ability to toilet) (Grade A)
- screen for depression (Grade B)
- assess cognitive status (Grade C)
- any medications that could cause or worsen
UI (ICI recommendation)
- any medical conditions that could cause or
worsen UI (ICI recommendation)
• Urinalysis should be undertaken (including for
haematuria, leucocytes, nitrites) (Grade C)
• Undertake wet checks to assess frequency of
urinary incontinence (Grade C)
• Ensure diagnosis of the type of UI is recorded
(ICI recommendation):
- Urgency
- Stress
- Mixed
- Other
3. An individualised treatment plan should be in
place for:
• Individualised goals of care (Grade C)
• Treatment preferences of resident and/or next
of kin (Grade B)
• Bladder retraining (Grade A), or tailored
prompted voiding [if able to state name] (Grade
A)
• Degree of bother to resident/next of kin of UI
(Grade B)
4. Specialist referral should be made if needed (pain,
haematuria, UI not classified at urgency, stress or
mixed). (ICI recommendation).
Ethical Issues The researchers will adhere to ethical
standards for research involving people. In addition, all
researchers will abide by their institutional and national
ethical requirements. Ethical Committee approval was
obtained in England, Sweden, and Republic of Ireland.
In the Netherlands, the researchers were advised to get
permission from either an ethical committee at site
level, or where this did not exist, from a scientific or
residents committee at the site. Research Governance
approval was also obtained in England, and permission
to collect data at the sites obtained in Sweden and
Republic of Ireland.
Outcomes
Primary outcome Percentage compliance with conti-
nence recommendations (Additional file table S1) will
be calculated, and a data profile constructed.
Secondary outcomes
Clinical outcomes These include number of referrals
for specialist continence assessment, incidence of docu-
mented incontinence-related dermatitis, urinary tract
infections (documented as confirmed by laboratory, con-
firmed by dipstick or confirmed by symptoms only), and
patients’ health-related quality of life using I-QoL
[45,46] and the EQ-5D [47,48]. The impact of length of
stay will be investigated in the analysis, treating length
of stay as a co-variant.
Process evaluation data The embedded process evalua-
tion will focus on four areas: facilitation residential pro-
gramme evaluation; facilitation (i.e., intervention)
implementation (i.e., how the intervention plays out in
practice); influences on implementation (i.e., enablers
and barriers); and the impact of intervention implemen-
tation on continence care processes and care home
environments.
Qualitative and quantitative data collection methods
will be used to strengthen our conclusions through
method triangulation. Consistent with a realistic evalua-
tion approach [20,49] our approach to data collection,
analysis and integration will be guided by a number of
propositions, developed in the initial stages of the study
from our conceptual framework, which will be tested
throughout the study.
Methods of data collection for process evaluation
data Data are being collected through interviews with
relevant stakeholders including staff, residents, and next
of kin, a questionnaire to assess the context of practice
(Alberta Context Tool, ACT), observations and docu-
mentary evidence. Our intention is to construct a com-
prehensive picture of the impact of facilitation on
continence practice, nursing home contexts, and
residents.
The Alberta context tool ACT has been designed to be
a reliable and valid measure of context within complex
healthcare settings where care is provided to patients/
residents [29]. The ACT is a short questionnaire based
on the construct of context (culture, leadership, evalua-
tion) within the PARIHS framework. Additionally, it
assesses a number of other concepts that have been
found to be important in knowledge translation activity,
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including structural resources, social capital, organiza-
tional slack, and formal interactions. ACT has been
designed to be completed by individual care providers,
and a number of different versions have been developed
for different disciplines and levels of nurses (see [29] for
more details). The administration of this instrument will
provide us with an assessment of the context in which
care is being delivered within the study’s nursing homes,
and any factors that may explain implementation activity
and outcome. Our target sample for the ACT is 30 staff
in each home. All nursing staff (licensed practical
nurses, registered nurses, and healthcare assistants) who
plan and deliver direct care to residents, including conti-
nence care, will be asked to complete the questionnaire
and return it directly to the research team and/or data
entry company. Staff will be identified by the local link
person, and the survey administered through the inter-
nal postal system. The survey will be administered on
three occasions: at baseline, then 12 and 24 months
after the intervention. Consent to participate in this part
of the study will be assumed if the person decides to
complete and return the questionnaire. A second distri-
bution of the questionnaire with a letter reminding staff
will be sent to all staff between three and six weeks
after the first distribution.
Interviews Semi-structured interviews (telephone and
face-to-face) will be conducted with internal and exter-
nal facilitators, staff, stakeholders, and residents as well
as their next of kin during the lifetime of the project.
Interviews will be conducted at critical points in the
programme pre-, during, and post-intervention. Inter-
views will focus on the experience of implementation,
barriers and facilitators, key events, social, political, and
financial aspects of care and service delivery, and more
specifically how continence care is delivered. The ques-
tions asked in interview will be adapted, depending on
the purpose of the interview, and who the stakeholder
is.
Data from interviews will enable the capture of inter-
vention specific process information (i.e., about conti-
nence care) as well as more general features of the
study sites with which to contextualise outcome data
from the main intervention project. Interviews will be
audio-recorded, and later transcribed.
Non-participant observation We will undertake non-
participant observation of care delivery, significant
events in the implementation processes and facilitation
residential programmes. Non-participant observation
will contribute to identifying barriers and facilitators to
implementation and practice change, to provide evi-
dence about the role and influence of the facilitators
including identifying what are the elements of the role
that contribute to ‘good enough’ facilitation, the reasons
for the particular adaptations of the facilitation models
to local contexts, and the interactions between facilita-
tion and the context(s) of care.
Observations will be recorded as field notes, including
descriptive accounts, and interpretive/reflective com-
ments. Where appropriate and possible, interviews will
be timed to follow periods of non-participant observa-
tion. Observations will be informed by nine dimensions
(space, actors, activities, objects, acts, events, time, goals,
and feelings) [50] and the elements contained in the
evaluation strands. Anyone who does not wish to be
observed will not be part of the observation and no data
will be collected relating to them.
Routinely collected data We will gather any available
routinely collected local data relevant to the delivery of
continence care, and to help us understand the context
of care. This may include, for example, an audit of con-
tinence care or product use.
Documentation Relevant continence care specific docu-
mentation will be collected from each site such as poli-
cies, procedures, and guidelines. These should provide
useful sources of information about expected continence
care practice. Documents will be monitored through
from pre- to post- intervention, and any changes made
to them noted.
Intervention-specific process data Process data will be
collected by facilitators as part of both facilitation inter-
ventions, which may include for example the adminis-
tration of the Context Assessment Index [51], internal
facilitators’ activity logs, any audits or other evaluations
they or the nursing homes conduct during the project,
data collected routinely as part of the facilitators’ devel-
opment programmes (e.g., portfolios or reflective diaries,
supplies data, policy documents), data collected as a
requirement of registration of external audit procedures
(appropriate permissions to use these data in anon-
ymised form will be sought).
Economic evaluation The embedded economic evalua-
tion will take a public sector, multi-agency perspective
[52,53]. The analysis will be guided methodological best
practice for conducting economic evaluations and cost
analyses of guideline implementation strategies [54].
The interventions (i.e., facilitation models to enhance
compliance with the recommendations) will be fully
costed using the finance records plus internal facilitator
diaries to record any additional costs that are not fully
funded by the study. We will take care to distinguish
between research costs and true intervention costs.
These facilitation model costs will include residential
schools, teleconferencing, travel, salaries, locum support,
study time, email, and other support time. In order to
find out the ongoing costs of managing continence at
study sites, we will collect staff activity and incontinence
product use information. Nationally agreed midpoint
salaries for the staff grade will be attributed, as
Seers et al. Implementation Science 2012, 7:25
http://www.implementationscience.com/content/7/1/25
Page 7 of 11
appropriate to each participating country. Interviewers
will collect costs and types of incontinence products
from residential site managers. The time horizon for the
trial is two years. All costs will be reported in Euros for
the year of study completion. Costs in year two will be
discounted at appropriate rates. We will conduct a pri-
mary cost-effectiveness analysis to determine cost (in
Euros) of achieving various levels of compliance (%)
with the recommendations. We will conduct a second-
ary cost consequence analysis comparing the costs of
different facilitation models with a full range of conse-
quences. Amongst these consequences will be self- and
proxy-reported health-related quality of life using EQ-
5D [55]. Sensitivity analyses will be conducted to see
how level of compliance with the recommendations var-
ies according to our assumptions. In our cost effective-
ness analysis, we will fully address uncertainty and use
cost-effectiveness acceptability curves (CEACs) to con-
vey to policy makers the probability that facilitation
models are cost effective at different payer thresholds e.
g., £20,000 to 30,000 used by NICE in UK. Subgroup
analysis will consider important predictors that may
affect quality of life during follow-up, including age,
dementia status, or those referred for an incontinence
assessment, presence of incontinence related dermatitis,
and country of residence.
Sample size
Power calculation There is no information available on
the current level of compliance with the recommenda-
tions, so for the purposes of the power calculation our
initial assumption is that there is 50% compliance. It is
assumed that in each nursing home 50 patients would
be available for assessing compliance with the recom-
mendations. For 90% power to detect if compliance with
the recommendations is 15% better in the facilitation
arms compared to the standard dissemination arm and
allowing for an intracluster correlation of 0.01 and sta-
tistical tests carried out at the 5% level, we will, for clus-
ter size 50, require 7 clusters (nursing homes) per
intervention arm [56]. Thus 21 clusters in all will be
needed. Allowing for potential attrition, this is increased
to 8 clusters per intervention arm, so 24 clusters in
total. This equates to 6 long term nursing care settings
per country with 50 patients per long term care setting.
If compliance with recommendations is lower than
50%, for example 10% (0.1) then for 50 residents per
cluster, 4 clusters would be needed per intervention
(total 12 clusters). If there were 20 residents per cluster,
then 8 clusters per intervention would be needed (total
24), and if 10 residents per cluster then 14 clusters per
intervention (total 42) would be needed.
This gives the range of number of clusters potentially
needed, given lack of information on current compli-
ance, and allowing for a range of numbers of available
residents in each cluster. In this study, it was decided
that having 8 clusters per intervention (total 24) would
give the study the best chance of detecting a 15%
improvement in compliance between the standard disse-
mination and facilitation arms.
Qualitative sample size Up to five members of nursing
staff, five residents, five next of kin and managers and
other stakeholders will be interviewed in each site at
baseline. Exact numbers will be determined by data
saturation and local factors. Further interviews to
explore the processes of implementation and its impact
will be conducted at points during the study where
there have been changes either to continence care or in
the context locally at the home, region or nationally.
Randomisation In each country (UK, Sweden, Nether-
lands, and Republic of Ireland), six sites will be selected
which meet the inclusion criteria. These sites will be
randomised from a central randomisation point, which
will ensure allocation concealment. We will use a strati-
fied random allocation, stratifying by country, and
within each strata we will use randomised block of size
six. Each site will be randomly allocated to one of three
groups: standard dissemination; Type A (technical) facil-
itation; or Type B (enabling) facilitation. In each country
there will be two sites randomly allocated to each arm.
The randomisation schedule will be computer generated
and prepared by a statistician who is independent of the
project team. The country co-ordinators will convey
allocation to each site to ensure the research fellows
remain blinded.
Blinding There are many challenges of maintaining
blinding in this study. However, research fellows collect-
ing outcome and process data will be blind to the ran-
dom allocation of each site for baseline data collection.
From previous experience, we anticipate that the blind-
ing may be inadvertently broken by the sites either dur-
ing or after baseline data collection. (For example, by
referring to external facilitators by name). If and when
blinding is broken will be recorded for each site. It is
not possible to blind the external facilitators delivering
the facilitation programmes as they are delivering the
programme because they have specific expertise in that
type of facilitation.
Timing of data collection Baseline data will be col-
lected at each site before the intervention. The interven-
tion will take place over 12 months in arm two, and
over 24 months in arm three. Outcome data will be col-
lected at 6, 12, 18, and 24 months after the start of the
intervention for all groups. This will be concurrent with
longitudinal process evaluative data collection.
Translations Interview schedules and recommendations
were translated into Dutch and Swedish. These transla-
tions were checked by the country co-ordinators. The
Quality of Life Scales already had validated Swedish and
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Dutch versions. The Alberta Context Tool was trans-
lated into Swedish and Dutch. A systematic process of
translation, back translation, revision, and feasibility
assessment based on several years experience and trans-
lation into several languages with the ACT was followed.
Research fellow training Research Fellow training was
provided before baseline data collection to ensure a
common understanding of the process, and reinforced
at training sessions throughout the study.
Analysis
Quantitative analysis Data will initially be entered
onto an excel spreadsheet, uploaded by each country
onto a secure central site, and then transferred to SPSS
version 18 for analysis. An intention to treat analysis
will be carried out on the primary and secondary out-
comes. Descriptive statistics will be calculated for all
variables of interest. Continuous measures will be sum-
marised using means and standard deviations; categori-
cal variables will be summarized using counts and
percentages. Descriptive analyses within and across data
sets and within and across sites by country, as well as
across countries, will be carried out.
The primary outcome measure, compliance with the
recommendations, will be compared at cluster level [56].
Repeated measures analysis of variance will be used to
investigate the change in compliance over time by inter-
vention group. Analysis of subgroups and of changes
between specific time points can be explored with t-
tests or analysis of variance and where appropriate mul-
tilevel hierarchical modelling will be used. However, the
study is not expected to be sufficiently powered for
detailed subgroup analysis.
A Data Management and Monitoring Committee has
been set up with agreed terms of reference to review
quantitative data management and monitor emerging
results.
Qualitative analysis Each set of data will first be ana-
lysed separately first using a thematic content analysis,
within a realist evaluation framework [40]. This
focuses the analysis on developing and testing theories
of what works, for whom, how, and in what circum-
stances by identifying outcomes, and the contexts and
the mechanisms by which the outcomes are achieved.
The data sets will then be synthesised drawing on the
principles of realistic evaluation. We anticipate that it
may be possible to generate some mid-range theory
from this data analysis that will contribute to better
understanding ‘good enough’ models of facilitation for
implementing guideline recommendations and the
influences of context on the processes of
implementation.
Qualitative data will managed through AtlasTi. Data
analysis will be an iterative process between data sets
and study phases. Integration and synthesis of data will
be guided by our theoretical framework and principles
of conducting mixed methods research [57].
Knowledge translation strategy An integrated knowl-
edge transfer strategy underpins the study, encompass-
ing three key strands of activity. First, we are developing
and implementing a model of stakeholder involvement
that complements the theory-driven approach to the
study design and enables stakeholder involvement
throughout the research process. Second, we are devel-
oping a portfolio of networking and dissemination activ-
ities that will promote active diffusion of the study
findings to key individuals and organisations in the EU,
Europe and internationally. Third, we will be supporting
study participants to disseminate their experiences and
learning as a result of their involvement in the research,
thus enhancing the sustainability and spread of the
study findings. We will evaluate the effectiveness of sta-
keholder involvement and dissemination activities as the
study progresses and revise accordingly.
Study governance The Committee and Management
Structure include:
1. A project board comprising all members of the con-
sortium, chaired by project co-ordinator.
The Project Board assures co-ordination and supervi-
sion of all activities, including time lines and project
reports and publications. The Board will meet twice a
year, and maintain regular communication as appropri-
ate. Decisions will be normally taken by consensus. In
exceptional cases where this is not possible a majority
vote will be used.
2. An advisory committee comprising key stakeholders
and including external experts, to provide advice and
review progress.
Their role is to provide advice, guidance, and chal-
lenge to the project board throughout the project, and
to help ensure the research contributes to knowledge at
a European and International level, but final responsibil-
ity lies with the project board. This committee will meet
three times, at the start, mid- and end-phases of the
study (6, 24, and 42 months).
Management of study KS is the overall project co-ordi-
nator. Each country site will be managed and overseen
by a member of the consortium nominated as country
co-ordinator. (Sweden LW; Republic of Ireland BMcC;
Netherlands KC; UK JRM).
Discussion
Initial experiences with data collection so far suggest
this pan-European study is complex to run, with many
and varied challenges. A ‘lessons learned’ log and risk
register are important aspects of managing these
challenges.
New understandings and empirical testing of the facil-
itation element of the PARIHS framework have the
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potential to make substantial contributions to knowl-
edge in this area.
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